Creative Planning’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-133,740
Closed 2163
2019
Q3
$0 Buy
133,740
+4,740
+4% +$31 ﹤0.01% 2154
2019
Q2
$1K Hold
129,000
﹤0.01% 2013
2019
Q1
$2K Buy
129,000
+35,000
+37% +$529 ﹤0.01% 1946
2018
Q4
$0 Buy
94,000
+500
+0.5% +$46 ﹤0.01% 2182
2018
Q3
$24K Buy
93,500
+5,000
+6% +$1.14K ﹤0.01% 1939
2018
Q2
$25K Hold
88,500
﹤0.01% 1898
2018
Q1
$22K Hold
88,500
﹤0.01% 1882
2017
Q4
$32K Hold
88,500
﹤0.01% 1830
2017
Q3
$62K Buy
88,500
+700
+0.8% +$334 ﹤0.01% 1759
2017
Q2
$35K Hold
87,800
﹤0.01% 2801
2017
Q1
$36K Buy
87,800
+10,000
+13% +$4.55K ﹤0.01% 2717
2016
Q4
$39K Hold
77,800
﹤0.01% 2595
2016
Q3
$88K Buy
77,800
+1,800
+2% +$1.93K ﹤0.01% 1943
2016
Q2
$87K Buy
76,000
+2,200
+3% +$2.74K ﹤0.01% 1767
2016
Q1
$134K Buy
73,800
+3,200
+5% +$4.46K ﹤0.01% 1455
2015
Q4
$119K Buy
70,600
+10,600
+18% +$26.9K ﹤0.01% 1528
2015
Q3
$180K Hold
60,000
﹤0.01% 1253
2015
Q2
$84K Hold
60,000
﹤0.01% 992
2015
Q1
$63K Hold
60,000
﹤0.01% 1858
2014
Q4
$73K Buy
+60,000
New +$59.3K ﹤0.01% 1741

Creative Planning's APDNW Position: Q4 2019 in Review

Creative Planning sold out of Applied DNA Sciences Inc Warrant (APDNW) in Q4 2019, closing a stake of 133,740 shares.

Creative Planning first reported a position in APDNW in Q4 2014 and held it in 20 quarters. The position peaked at $180K in Q3 2015. 0 funds tracked by Wall St. Rank hold APDNW as of Q4 2019.

  • Creative Planning reported no remaining Applied DNA Sciences Inc Warrant position as of Q4 2019 after selling out during the quarter.
  • Creative Planning sold 133,740 Applied DNA Sciences Inc Warrant shares in Q4 2019.
  • Creative Planning first reported a position in Applied DNA Sciences Inc Warrant in Q4 2014 and held it in 20 quarters.
  • Creative Planning's Applied DNA Sciences Inc Warrant position peaked at $180K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q4 2019.

Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.